Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

CGR - STRENGTHENING OF DMS GROUP'S GOVERNANCE STRUCTURE: APPOINTMENT OF JULIEN DELPECH AS AN INDEPENDENT DIRECTOR

Company: Diagnostic Medical Systems Date: 2025-06-17 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.pdf) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

![](_page_0_Picture_0.jpeg)

DMS Group: Renforcement of the Governance Structure

## **STRENGTHENING OF DMS GROUP'S GOVERNANCE STRUCTURE: APPOINTMENT OF JULIEN DELPECH AS AN INDEPENDENT DIRECTOR**

**June 17, 2025 – 8:00 am – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS and FR001400IAQ8 – DMSBS),** a specialist in high-performance medical imaging systems for digital radiology and bone densitometry, announces the strengthening of its governance structure.

At the Annual General Meeting of June 16, 2025, the shareholders approved the appointment of **Julien DELPECH**, 51 years old, who joins the Board of Directors of DMS Group as an **independent Director**.

With first-rate entrepreneurial experience, Julien DELPECH is the founder of the startup Invivox, the French specialist in online medical training. He is now a member of the board of French Healthcare, an association in charge, among other things, of Ukraine and is a Foreign Trade Advisor for France.

He will bring to Marie-Laurence BORIE, Léone ATAYI and Jean-François GENDRON, his international expertise and his knowledge of national and European institutions.

For his part, Régis ROCHE has resigned from his position as Director. Mr. ROCHE has successfully supported the Group's transformation since the change of governance in 2022. He remains a significant shareholder of the Group and we would like to thank him for his collaboration.

![](_page_1_Picture_0.jpeg)

## **ABOUT DMS GROUP**

DMS Group is a French digital radiology manufacturer, internationally oriented, recognized as a key player and a key partner in the value chain, both for the quality of its solutions, and for its flexibility, ingenuity and responsible values.

In 2024, DMS Group achieved a consolidated turnover of €46.1 million, 75% of which was international, with a presence on all continents through a network of more than 140 national distributors.

DMS Group is listed on the Euronext Growth Paris market (ISIN: FR0012202497 - ticker: ALDMS) and is eligible for the PEA-PME.

On June 13, 2023, DMS Group granted Warrants for Shares listed on the Euronext Growth market in Paris (ISIN: FR001400IAQ8 – ticker: DMSBS) and exercisable until September 12, 2025.

DMS Group is part of the ETIncelles program for SMEs that have the ambition and the desire to become midcaps.

![](_page_1_Picture_7.jpeg)

## **CONTACTS**

**Investor Relations**  [relationinvestisseur@dms-imaging.com](mailto:relationinvestisseur@dms-imaging.com)

**Press Relations** [relationpresse@dms-imaging.com](mailto:relationpresse@dms-imaging.com)

Unlock Europe's Largest Financial Database—Free

Get instant access to over 2.8M filings from 8,970 companies across 44 markets. No cost. No hassle. Just results.

Save hours with instant data access
Trusted by leading financial institutions
Free forever—no strings attached

Or sign up with

Google Microsoft

Or log in with

Google Microsoft

This premium feature is designed for professionals. Upgrade your plan to gain immediate access and enhance your research capabilities.

Upgrade Now